BASILAR ARTERY OCCLUSION
Clinical trials for BASILAR ARTERY OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new BASILAR ARTERY OCCLUSION trials appear
Sign up with your email to follow new studies for BASILAR ARTERY OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could save lives in rare, deadly stroke
Disease control Recruiting nowThis study tests a drug called tenecteplase for people having a severe stroke caused by a blockage in the basilar artery at the back of the brain. Participants receive either standard care or tenecteplase within 24 hours of symptoms, followed by a procedure to remove the clot if …
Matched conditions: BASILAR ARTERY OCCLUSION
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated May 17, 2026 10:09 UTC
-
Clot-Busting drug before transfer may save lives in severe stroke
Disease control Recruiting nowThis study looks at whether giving a clot-dissolving drug called tenecteplase before transferring patients with a severe type of stroke (basilar artery occlusion) to a hospital that can perform clot removal improves recovery. The trial involves 316 adults who had a stroke 4.5 to …
Matched conditions: BASILAR ARTERY OCCLUSION
Phase: PHASE4 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for late-stage stroke: procedure may restore function days after onset
Disease control Recruiting nowThis study tests whether a procedure to reopen a blocked artery in the back of the brain can help people who had a severe stroke 24 to 72 hours earlier. About 224 adults will be randomly assigned to get either the procedure or standard medical care. The goal is to see if more peo…
Matched conditions: BASILAR ARTERY OCCLUSION
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated May 07, 2026 18:42 UTC